Search

Search Results

• CO-25 | MILD HEMOPHILIA A AND JOINT HEALTH IN REAL LIFE: IS THAT AN EMERGING ISSUE? A SINGLE CENTER EXPERIENCE F. Valeri¹, G. Murante¹, C. Dainese¹, M. Capetta¹, S. Bergonzi¹, R. Pastorino¹, F. Bocchi¹, B. Bruno², A. Borchiellini¹ | ¹Regional Centre for Haemorrhagic and Thrombotic Disease, Hematology Division, AOU Città della Salute e della Scienza, Torino, Italy; ²Division of Hematology, AOU Città della Salute e della Scienza, Department of Molecular Biotechnology and Health sciences, University of Turin, Italy

  Federica Valeri

  14-10-2026

  https://doi.org/10.4081/btvb.2026.635

  48

  PDF: 14

• CO-89 | FEMORAL FRACTURE SURGERY IN AN ELDERLY, FRAIL PATIENT WITH ACQUIRED HEMOPHILIA A RECEIVING EMICIZUMAB PROPHYLAXIS: A CASE REPORT C. Simion^1|2, E. Zanon^1|2, B. Stocco^1|2, F. Sartorello¹, C. Bulato¹, G. Saggiorato¹, P. Simioni^1|2 | ¹First Chair of Internal Medicine and Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Italy; ²Hemophilia Center, Padova University Hospital, Italy

  Chiara Simion

  14-10-2026

  https://doi.org/10.4081/btvb.2026.699

  42

  PDF: 19

• CO-54 | DECREASED BONE MINERAL DENSITY IN HEMOPHILIA IS NOT CORRELATED WITH INCREASED RISK OF FRACTURES M.R. Fasulo¹, F. Carrone², G. Mazziotti^3|4, A. Colombo¹, C. Lodigiani¹, M.E. Mancuso^1|4 | ¹Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ²Endocrinology and Diabetology Unit, Humanitas Mater Domini, Castellanza, Varese, Italy; ³Endocrinology, Diabetology and Medical Andrology Unit, Metabolic Bone Diseases and Osteoporosis Section, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ⁴Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy

  Maria Rosaria Fasulo

  14-10-2026

  https://doi.org/10.4081/btvb.2026.664

  38

  PDF: 16

• CO-78 | REAL-WORLD MANAGEMENT OF ACQUIRED HEMOPHILIA A: FOCUS ON RECOMBINANT PORCINE FVIII AS FIRST-LINE HEMOSTATIC TREATMENT AND LONG-TERM OUTCOMES M. Leotta, A. Strangio, A. Ierardi, R.C. Santoro | Hemophilia, Hemostasis and Thrombosis Centre, Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

  Marzia Leotta

  14-10-2026

  https://doi.org/10.4081/btvb.2026.688

  44

  PDF: 16

• CO-38 | CALIBRATION OF HUMAN COAGULATION FACTOR VIII IN NOVEL QUALITY CONTROL MATERIALS: A COLLABORATIVE STUDY G. Gullifa¹, A. Carocci¹, C. Albertini^1|2, L. Luchetti¹, M.T. Pasquino¹, M. Simeoni¹, L. Mandarino¹, C. Adriano^1|3, R. Risoluti³, S. Massimi¹ | ¹Centro Nazionale per il Controllo e la Valutazione dei Farmaci, Istituto Superiore di Sanità, Roma, Italy; ²Centro Nazionale Sangue, Istituto Superiore di Sanità, Roma, Italy; ³Sapienza Università di Roma, Italy

  Giuseppina Gullifa

  14-10-2026

  https://doi.org/10.4081/btvb.2026.648

  40

  PDF: 15

• PO49 | Use of emicizumab in two patients with acquired hemophilia A: a new therapeutic approach S. Sorella, J. Micozzi, E. Baldacci, M. Biglietto, R. Mormile, A. Chistolini, R. Ciciani, L. Torrieri, N. Zhdanovskaya, M. Lorenzon, A. Delli Paoli, S. Ligia, C. Santoro | Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.318

  665

  PDF: 25
• 

  Development of a shared decision-making tool for gene therapy in hemophilia A in Italy

  Giovanni Di Minno, Sarah Bigi, Serena Barello, Enrico Ferri Grazzi, Marco Follino, Maria Francesca Mansueto, Mariasanta Napolitano, Rita Carlotta Santoro, Giancarlo Castaman

  22-06-2026

  https://doi.org/10.4081/btvb.2026.426

  933

  PDF: 139

  SUPPLEMENTARY MATERIAL: 78

• CO36 | Inhibitor titer at diagnosis and clinical course in acquired hemophilia A: a single-center experience C. Simion, B. Stocco, E. Dalla Porta, E. Campello, G. Furlan, L. Spiezia, G. Saggiorato, F. Sartorello, E. Zanon, P. Simioni | Department of Medicine – DIMED, University of Padua, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.243

  588

  PDF: 33
• 

  Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

  Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

  17-10-2022

  https://doi.org/10.4081/btvb.2022.40

  3064

  PDF: 434

• CO35 | Bleeding phenotype characterization in patients with congenital bleeding disorders: a multigenic approach using next generation sequencing to identify coagulation-modulating variants C. Simion, L. Gianesello, C. Bulato, A. Benetti, E. Campello, A. Giannella, G. Ceolotto, E. Zanon, L. Spiezia, P. Simioni | Department of Medicine – DIMED, University of Padua, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.242

  544

  PDF: 31

• PO060 | DISCREPANCY IN FACTOR VIII LEVELS AMONG HEMOPHILIA A CARRIERS: ONE-STAGE VS. CHROMOGENIC ASSAY A. Strangio, M. Leotta, A. Ierardi, L. Elia, M. Falbo, C. Condina, G. Procopio, RC Santoro | Centro Emofilia AOU R. Dulbecco Catanzaro, Italy

  Alessandra Strangio

  26-10-2026

  https://doi.org/10.4081/btvb.2026.876

  24

  PDF: 8
• 

  The changing landscape of treatment for acquired hemophilia A

  Massimo Franchini, Daniele Focosi

  30-01-2025

  https://doi.org/10.4081/btvb.2025.157

  2073

  PDF: 548

• CO-70 | CONGENITAL AFIBRINOGENEMIA: BLEEDING PHENOTYPE, THROMBOTIC COMPLICATIONS, AND LONG-TERM MANAGEMENT IN A MULTICENTER COHORT M. Biglietto^1|2, M. Presti¹, R.C. Santoro³, I. Nichele⁴, M. Napolitano⁵, S. Pasca⁶, A. Borchiellini⁷, B. Pollio⁸, E. Zanon⁹, G. Barillari¹⁰, A. Poz¹⁰, S. Sorella¹, S. Ligia¹, R. Mormile¹, E. Baldacci¹, G. Castaman¹¹, F. Peyvandi^12|13, C. Santoro¹ | ¹Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Italy; ²Department of Molecular Biology, Sapienza University of Rome, Italy; ³Hemostasis and Thrombosis Unit, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy; ⁴Hematology Unit, Azienda ULSS 8 Berica - San Bortolo Hospital, Vicenza, Italy; ⁵Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Italy; ⁶Coagulation Diseases Center, Transfusion Medicine Department - Azienda Sanitaria Universitaria Integrata del Trentino, Trento, Italy; ⁷Centro di Riferimento Regionale Malattie Emorragiche e Trombotiche dell'Adulto, Divisione di Ematologia, Università Città della Salute e della Scienza di Torino, Italy; ⁸SIMT Immunohematology and Transfusion Medicine Service, Diagnostic Department, A.O. Città della Salute e della Scienza, Torino, Italy; ⁹Department of Medicine, Haemophilia Centre, University Hospital of Padua, Italy; ¹⁰Center for Hemorrhagic and Thrombotic Diseases, General and University Hospital S. Maria della Misericordia, Udine, Italy; ¹¹Centre for Bleeding Disorders and Coagulation, Careggi University Hospital, Firenze, Italy; ¹²IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; ¹³Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milano, Italy

  Mario Biglietto

  14-10-2026

  https://doi.org/10.4081/btvb.2026.680

  43

  PDF: 16

• BEST-05 | LONG-TERM EMICIZUMAB PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A: REAL-WORLD EXPERIENCE ACROSS ALL AGES A. Colombo¹, I. Quaglia¹, M.R. Fasulo¹, C. Lodigiani¹, M.E. Mancuso^1|2 | ¹Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ²Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy

  Arianna Colombo

  14-10-2026

  https://doi.org/10.4081/btvb.2026.605

  93

  PDF: 14

• PO12 | Characterisation and real word clinical data of HEM006, a newly formulated intranasal spray desmopressin (DDAVP) to address a global treatment gap G. De Giorgi¹, A. Gringeri², R. Franceschini¹, A. Koganti³ | ¹Hemorare Srl, Italy; ²Fondazione Charta, Milan, Italy; ³Quenya LLC, USA

  22-10-2025

  https://doi.org/10.4081/btvb.2025.274

  580

  PDF: 12

• PO039 | CLINICAL AND LABORATORY CHARACTERISTICS OF ACQUIRED HEMOPHILIA A: PRELIMINARY RESULTS FROM A RETROSPECTIVE OBSERVATIONAL MONOCENTRIC STUDY S. Suardi¹, M. Bodini², A.C. Giuffrida², A. Zanzanelli³, S. Moruzzi¹, L. Delfino¹, F. Pizzolo¹, S. Genesini², M. Cantini², C. Spillere¹, L. Panepinto¹, F. Zoccatelli¹, E. Malloggi¹, F. Presa¹, A. Moschella¹, M. Merlo¹, G. Gandini², S. Friso¹, N. Martinelli¹ | ¹Department of Medicine, Unit of Internal Medicine B, Azienda Ospedaliera Universitaria Integrata di Verona, Italy; ²Department of Transfusion Medicine, Hemophilia Center, Azienda Ospedaliera Universitaria Integrata di Verona, Italy; ³Division of Internal Medicine, IRCCS Azienda Ospedaliero Universitaria Bologna, Italy

  Silvia Suardi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.855

  22

  PDF: 8
• 

  Is non-alcoholic fatty liver disease a prothrombotic risk factor?

  Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi

  19-05-2023

  https://doi.org/10.4081/btvb.2023.81

  1138

  PDF: 549

• CO-59 | CONCIZUMAB IN A YOUNG CHILD WITH SEVERE HEMOPHILIA B WITH INHIBITOR: EFFECTIVE BLEED CONTROL AND SAFE HOME MANAGEMENT T. Martini¹, B. Borsellino^1|2, B. Pollio¹ | ¹Hemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; ²Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy

  Tiziano Martini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.669

  44

  PDF: 13

• CO-22 | CLINICAL FEATURES IN PATIENTS WITH NON-SEVERE HEMOPHILIA A: THE DISCOVERY SCORE PROPOSAL FOR PROPHYLAXIS PRESCRIPTION M.N.D. Di Minno¹, E. Baldacci², C. Biasoli³, A. Borchiellini⁴, F. Daniele⁵, P. Di Gregorio⁶, C. Gorio⁷, G. Malcangi⁸, E. Marchesini⁹, I. Ricca¹⁰, R. Santoro¹¹, S. Siragusa¹², M.R. Villa¹³, E. Zanon¹⁴, A. Tagliaferri¹⁵, A. Coppola¹⁵ | ¹Hub Centre for Thrombotic and Hemorrhagic Disorders, Federico II University Hospital, Napoli, Italy; ²Haematology, University Hospital Policlinico Umberto I, Roma, Italy; ³Interdepartmental Simple Structure for the Management of Hemorrhagic and Thromboembolic Diseases, M. Bufalini Hospital, Cesena, Italy; ⁴Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza, Torino, Italy; ⁵Haemostasis and Thrombosis Service, Ospedale Civile dell'Annunziata, Cosenza, Italy; ⁶Transfusion Medicine Department, "SS. Annunziata" Hospital, Chieti, Italy; ⁷Pediatric Onco-Hematology Unit, Children's Hospital, ASST-Spedali Civili, Brescia, Italy; ⁸Haemophilia and Thrombosis Center, University Hospital Policlinico-Giovanni XXIII, Bari, Italy; ⁹Hemophilia Centre, SC Vascular and Emergency Department, University of Perugia, Italy; ¹⁰Centro Emofilia, Città della Salute e della Scienza, Torino, Italy; ¹¹Hemostasis and Thrombosis Unit, Azienda Ospedaliero Universitaria Dulbecco, Catanzaro, Italy; ¹²Centro di Riferimento Regionale per le Emocoagulopatie Congenite, Palermo, Italy; ¹³Hematology Unit, Ospedale Santa Maria di Loreto, Napoli, Italy; ¹⁴Hemophilia and Thrombosis Center, University Hospital of Padua, Italy; ¹⁵Hemophilia and Thrombosis Center, Azienda Ospedaliera di Parma, Italy

  Matteo Di Minno

  14-10-2026

  https://doi.org/10.4081/btvb.2026.632

  55

  PDF: 15

• CO006 | PREVALENCE OF GASTROINTESTINAL BLEEDING IN GLANZMANN THROMBASTHENIA PATIENTS: RESULTS OF A WORLDWIDE SURVEY E. Falcinelli¹, L. Bury¹, S. Morais², M. de Oliveira², M. Kannan³, M. Faranoush⁴, D. Desprez⁵, V. Jean-Baptiste⁶, C. Santoro⁷, C. Falaise⁸, P. Saultier⁸, M. Fiore⁹, C. Albayrak¹⁰, A. Sánchez¹¹, J.M. Bastida¹², A. Artoni¹³, G. Castaman¹⁴, K. Gomez¹⁵, R. Schutgens¹⁶, L. Spiezia¹⁷, M. Sridharan¹⁸, N. Butta¹⁹, P. Buur van Kooten Niekerk²⁰, E. Leinøe²¹, B. Guillet²², C. Panagiotis²³, S. Crivelli²⁴, E. De Candia²⁵, M. Lewandowska²⁶, P. De Bonis²⁷, G. Kenet²⁸, F. Heubel-Moenen²⁹, J. Payne³⁰, L. Banov³¹, L. Puccetti³², M. Olivieri³³, M. Chitlur³⁴, M. Lambert³⁵, A. Pecci³⁶, D. Martínez-Carballeira³⁷, E. Zetterberg³⁸, J. Curnow³⁹, M. Napolitano⁴⁰, A. Morotti⁴¹, R.C. Santoro⁴², R. Johann⁴³, S. Saulyte Trakymiene⁴⁴, A. Falanga⁴⁵, C. Casas⁴⁶, E. Zanon⁴⁷, J. Moppet⁴⁸, N.M. Popa-Fotea⁴⁹, P. Gresele¹ | ¹Department of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia, Italy; ²Centro Hospitalar Universitário de Santo António, Portugal; ³Blood and Vascular Biology Research Lab, Department of Biotechnology, Central University of Tamil Nadu, India; ⁴Iranian Hemophilia and Thrombophilia Association, MAHTA, Iran; ⁵CRC MHC Hopital Universaitire de Strasbourg, France; ⁶CHRU de Tours, University Hospital of Tours, France; ⁷UOC Ematologia, Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma, Italy; ⁸AP-HM Timone, Marseille, France; ⁹CHU Bordeaux, France; ¹⁰Mayıs University Medical Faculty Pediatric Hematology and Oncology Dept, Türkiye; ¹¹Hospital Universitario Morales Meseguer – Centro Regional de Hemodonación, Murcia, Spain; ¹²Complejo Asistencial Universitario De Salamanca, Spain; ¹³Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy; ¹⁴Azienda Ospedaliera Universitaria Careggi Florence, Italy; ¹⁵Royal Free Hospital, London, UK; ¹⁶Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, UMC Utrecht, The Netherlands; ¹⁷University of Padova, Italy; ¹⁸Mayo Clinic, Rochester, USA; ¹⁹Hospital Universitario La Paz-IdiPAZ, Madrid, Spain; ²⁰Aarhus University Hospital, Denmark; ²¹Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; ²²University Hospital of Rennes, France; ²³Blood unit and National Reference Center for Congenital Bleeding Disorders, ''Laiko'' General Hospital, Greece; ²⁴Ospedale L. Sacco e Polo Universitario, Milano, Italy; ²⁵Università Cattolica del Sacro Cuore-Roma, Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy; ²⁶Indiana Hemophilia and Thrombosis Center Innovative Hematology, USA; ²⁷IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; ²⁸Sheba Medical Center, Israel; ²⁹Department of Hematology Internal Medicine, Maastricht University Medical Center and Hemophilia Treatment Center Nijmegen Eindhoven Maastricht and CARIM, Maastricht University, Maastricht, Netherlands; ³⁰Sheffield Children’s NHS foundation Trust, UK; ³¹Hemostasis and Thrombosis Unit, Gaslini Children’s Hospital, Italy; ³²University Teaching Hospital of Siena, Italy; ³³Pediatric Thrombosis and Hemostasis Unit, Dr. von Hauner Childreńs Hospital, LMU Munich, Munich, Germany; ³⁴Children's Hospital of Michigan, USA; ³⁵Children’s Hospital of Philadelphia, USA; ³⁶IRCCS Policlinico San Matteo Foundation and University of Pavia, Italy; ³⁷Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain; ³⁸Department of Hematology, Coagulation Unit, Skane University hospital, Sweden; ³⁹Westmead Hospital, Sydney, Australia; ⁴⁰PROMISE Department, University of Palermo, Italy; ⁴¹AOU San Luigi Gonzaga Hospital, University of Turin, Italy; ⁴²Hemostasis and Thrombosis, Az. Osp. Univ. Dulbecco, Catanzaro, Italy; ⁴³Hospital Center of Le Mans, France; ⁴⁴Vilnius University Hospital Santaros Klinikos, Lithuania; ⁴⁵ASST Papa Giovanni XXIII, Bergamo, Italy; ⁴⁶Hospital San José, Bogotà, Colombia; ⁴⁷Haemophilia Center-General Medicine, Padova University Hospital, Padova, Italy; ⁴⁸University Hospitals Bristol NHS Foundation Trust, UK; ⁴⁹University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania

  Loredana Bury

  26-10-2026

  https://doi.org/10.4081/btvb.2026.708

  39

  PDF: 11

• CO-75 | ASSAY DISCREPANCY IN HEMOPHILIA A CARRIERS: CLINICAL AND GENETIC INSIGHTS M. Leotta, A. Strangio, A. Ierardi, R.C. Santoro | Hemophilia Treatment Center AOU Dulbecco, Catanzaro, Italy

  Marzia Leotta

  14-10-2026

  https://doi.org/10.4081/btvb.2026.685

  43

  PDF: 20

• CO-34 | SIMPLIFIED PERIOPERATIVE MANAGEMENT WITH N8-GP (TUROCTOCOG ALFA PEGOL) IN MAJOR ABDOMINAL SURGERY IN MILD HEMOPHILIA A WITH SEVERE BLEEDING PHENOTYPE: A CASE REPORT J. Di Paolo, R. Malizia, M. Luongo, P. Massaro, M. Di Mascio, S. Verna | Immunohematology Service, ASL 02 Abruzzo, Chieti, Italy

  Josephine Di Paolo

  14-10-2026

  https://doi.org/10.4081/btvb.2026.644

  36

  PDF: 13

• PO44 | Emicizumab in acquired haemophilia A M. Leotta, A. Strangio, A. Ierardi, S. Prejanò, R C. Santoro | Hemostasis and Thrombosis Unit, Department Hemato-Oncology, Azienda Ospedaliero-Universitaria Renato; Dulbecco, Catanzaro, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.307

  628

  PDF: 20

• PO114 | A CASE OF ACQUIRED HEMOPHILIA AFTER TAVI AND CORONARY ANGIOPLASTY IN PATIENT WITH ATRIAL FIBRILLATION AND MULTIPLES CARDIOVASCULAR RISK FACTORS – THE ART AND SCIENCE OF THERAPEUTIC CONFLICT M.M. Poggi¹, C. Tamburini², M. Littera², M. Mazzetti² | ¹SOC Medicina 1, Nuovo Ospedale Prato, Prato, Italy; ²SOD Medicina Interna Interdisciplinare, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy

  Matteo Maria Poggi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.930

  26

  PDF: 7

• CO33 | Acquired hemophilia A in Liguria, Italy: what six years of data reveal C. Vernarecci¹, A. C. Molinari¹, P. Ballarino², M. Caiti², E. Cenni², P. Moscatelli², L. Banov¹ | ¹IRCCS Istituto Giannina Gaslini, Genova; ²IRCCS Policlinico San Martino, Genova, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.240

  616

  PDF: 30

• PO67 | Pancreatic cancer in a 71-year-old severe hemophilia A patient with inhibitors and sustained zero bleeding during emicizumab prophylaxis M. Biglietto, A.L. Faccini, S. Sorella, E. Crisanti, M. Antonacci, A. Taglietti, M. Gherardini, A. Tirnetta, S. Ligia, R. Mormile, R. Ciciani, E. Baldacci, C. Santoro | Hematology, Department of Translational and Precision Medicine Sapienza University of Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.336

  668

  PDF: 29

• BEST-03 | CRISPR-CAS9 CORRECTION IN SEVERE HEMOPHILIA A A. Benetti¹, C.M. Radu¹, M. Trevisan², C. Samà¹, C. Simion¹, E. Campello¹, P. Simioni¹ | ¹First Chair of Internal Medicine and Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Italy; ²Department of Molecular Medicine, University of Padua, Italy

  Andrea Benetti

  14-10-2026

  https://doi.org/10.4081/btvb.2026.603

  83

  PDF: 16

• CO005 | HEPATIC ENDOTHELIUM AS A SAFE AND DURABLE TARGET FOR LENTIVIRAL GENE THERAPY OF HEMOPHILIA A E. Borroni, F. Antony, S. Merlin, V. Kalandadze, C. Borsotti, A. Follenzi | Università del Piemonte Orientale, Novara, Italy

  Ester Borroni

  26-10-2026

  https://doi.org/10.4081/btvb.2026.707

  38

  PDF: 9

• BEST-10 | CHANGES IN HYPERTROPHIC SYNOVIUM STATUS IN ADULT PATIENTS WITH SEVERE HEMOPHILIA A RECEIVING EMICIZUMAB PROPHYLAXIS: THE RESOLVE STUDY I.L. Calcaterra¹, M. Di Minno¹, E. Baldacci², G. D’Errico¹, C. Santoro², A. Strangio³, S. Sorella², M. Leotta³, R.C. Santoro³ | ¹Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy; ²Haematology, University Hospital Policlinico Umberto I, Roma, Italy; ³Hemostasis and Thrombosis Centre, Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

  Ilenia Lorenza Calcaterra

  14-10-2026

  https://doi.org/10.4081/btvb.2026.610

  88

  PDF: 17

• PO112 | REFRAMING THE ENIGMA: ACQUIRED HEMOPHILIA A AS A HARBINGER OF HHV-8–ASSOCIATED MULTICENTRIC CASTLEMAN DISEASE M. Palladino¹, G. Gammaitoni¹, C. Santoro², M. Muscaritoli¹ | ¹Medicina Interna e Nutrizione Clinica-Dip. Medicina Traslazionale e di Precisione; ²Ematologia- Dip. Medicina Traslazionale e di Precisione, Umberto I Roma, Italy

  Mariangela Palladino

  26-10-2026

  https://doi.org/10.4081/btvb.2026.928

  22

  PDF: 9

• PO131 | BEYOND THE INHIBITOR TITER: THE IMPORTANCE OF EARLY COMBINED IMMUNOSUPPRESSIVE THERAPY IN THE MANAGEMENT OF ACQUIRED HEMOPHILIA A M. Luongo¹, P. Massaro¹, M. Di Mascio¹, P.G. Simeone², F. Santilli², S. Verna¹ | ¹Immunohematology Service, Asl 02 Abruzzo, Chieti, Italy; ²Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti–Pescara, Italy

  Myriam Luongo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.947

  26

  PDF: 8

• CO081 | RESTORATION OF CEREBRAL MICROVASCULAR STRUCTURE AND FUNCTION IN HEMOPHILIA A MICE THROUGH FVIII GENE THERAPY G. Venturin¹, E. Spicuglia¹, S. Assanelli¹, C. Borsotti¹, A. Cucci¹, N. Keivan¹, E. Borroni¹, C. Sgromo¹, C. Olgasi², A. Follenzi^1|3 | ¹Department of Health Science, Università del Piemonte Orientale, Novara, 28100, Italy; ²Department of Translational Medicine, Università del Piemonte Orientale, Novara, 28100, Italy; ³Department of Attività Integrate Ricerca Innovazione, Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy

  Giorgia Venturin

  26-10-2026

  https://doi.org/10.4081/btvb.2026.783

  32

  PDF: 11

• CO-65 | COVID-19-ASSOCIATED HYPERCOAGULABILITY IN TYPE 2B VON WILLEBRAND DISEASE: INSIGHTS FROM GLOBAL HEMOSTATIC ASSAYS I. Condonato, C. Simion, E. Zanon, P. Simioni | Hemophilia Center, University Hospital of Padua, Italy

  Irene Condonato

  14-10-2026

  https://doi.org/10.4081/btvb.2026.675

  43

  PDF: 16

• CO002 | RETROSPECTIVE LONGITUDINAL ASSESSMENT OF JOINT HEALTH AND QUALITY OF LIFE IN ADOLESCENT AND ADULT PATIENTS AFFECTED BY MODERATE OR SEVERE HAEMOPHILIA A WITH OR WITHOUT INHIBITOR SWITCHING FROM INTRAVENOUS FVIII TREATMENT TO SUBCUTANEOUS PROPHYLAXIS WITH EMICIZUMAB S. Ceglie¹, R. Gualtierotti^1|2, S. Arcudi¹, A. Ciavarella¹, S.M. Siboni¹, F. Peyvandi^1|2 | ¹Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; ²Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milano, Italy

  Sara Ceglie

  26-10-2026

  https://doi.org/10.4081/btvb.2026.704

  51

  PDF: 12

• CS02 | Functional and structural impairments of the cerebral microcirculation in a mouse model of hemophilia A G. Venturin¹, C. Olgasi², C. Borsotti¹, P.E. Di Simone¹, E. Spicuglia¹ A. Cucci¹, C. Sgromo¹, A. Follenzi^2,3 | ¹Department of Health Science, Università del Piemonte Orientale, Novara; ²Department of Translational Medicine, Università del Piemonte Orientale, Novara; ³Department of Attività Integrate Ricerca Innovazione, Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.197

  753

  PDF: 21

• BEST-09 | IMMUNOGENIC IMPLICATIONS OF TRANSLATIONAL READTHROUGH MODULATE THE ASSOCIATION OF F8 NONSENSE MUTATIONS WITH INHIBITORS IN HEMOPHILIA A D. Balestra¹, M.F. Testa¹, M. Pinotti¹, A. Branchini¹, M.E. Mancuso², F. Bernardi¹ | ¹Department of Life Sciences and Biotechnology and LTTA Center, University of Ferrara, Italy; ²IRCCS, Humanitas Research Hospital, Center for Thrombosis and Hemorrhagic diseases, Milano, Italy

  Dario Balestra

  14-10-2026

  https://doi.org/10.4081/btvb.2026.609

  80

  PDF: 16

• PO085 | ACQUIRED HEMOPHILIA A IN THE SURGICAL PATIENT: DIAGNOSTIC AND THERAPEUTIC COMPLEXITY M. Luongo¹, P. Massaro¹, M. Di Mascio¹, P.G. Simeone², F. Santilli², S. Verna¹ | ¹Immunohematology Service, Asl 02 Abruzzo, Chieti, Italy; ²Department of Medicine and Aging Sciences, and Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti–Pescara, Italy

  Myriam Luongo

  26-10-2026

  https://doi.org/10.4081/btvb.2026.901

  25

  PDF: 7

• PO043 | MULTICENTRE REAL‑WORLD EXPERIENCE OF EMICIZUMAB PROPHYLAXIS IN AN ITALIAN COHORT OF 49 CHILDREN WITH SEVERE HEMOPHILIA A - EMIPED STUDY L. Pieri¹, B. Pollio², P. Giordano³, G. Lassandro⁴, S. Linari¹, R. Pasquino¹, E. Piellucci¹, MC. Di Stefano¹, F. Demartis¹, R. Fjerza¹, G. Castaman¹ | ¹Center for Bleeding Disorders, Careggi University Hospital, Firenze, Italy; ²Center for Inherited Bleeding and Thrombotic Disorders, Transfusion Medicine, "Regina Margherita" Children Hospital, Torino, Italy; ³Department of Interdisciplinary of Medicine, University of Bari 'Aldo Moro', Bari, Italy; ⁴General and Specialised Pediatrics Unit, "Giovanni XXIII" Hospital, University of Bari, Bari, Italy

  Lisa Pieri

  26-10-2026

  https://doi.org/10.4081/btvb.2026.859

  27

  PDF: 8

• CO-06 | ENHANCING SHARED DECISION-MAKING IN INHERITED BLEEDING DISORDERS: A SINGLE-CENTER QUALITY IMPROVEMENT INITIATIVE C. Manzi, L. Piscitelli, E. Zacchi, V. Caldi, L. Valdrè | Inherited Bleeding Disorders Unit, IRCCS AOU, Bologna, Italy

  Chiara Manzi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.616

  76

  PDF: 16

• PO55 | Evaluation of safety and efficacy of emicizumab prophylaxis in pediatric patients with hemophilia A – a single centre experience M.L. Tramontano, M. Coppola, S. Coppola, M. Schiavulli | UOSD Centro Regionale Pediatrico Malattie della Coagulazione, Santobono Pausilipon Children Hospital, AORN, Napoli, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.324

  573

  PDF: 24

• CO-47 | JOINT ULTRASOUND FOLLOW-UP IN PEDIATRIC PATIENTS WITH HEMOPHILIA: A 12-YEAR PROSPECTIVE SINGLE-CENTER EXPERIENCE I. Ricca¹, B. Borsellino^2|3, T. Martini², C. Martinoli⁴, B. Pollio² | ¹Transfusion Medicine, Ivrea Hospital, Ivrea, Italy; ²Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; ³Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy; ⁴Department of Health Science DISSAL, University of Genova, Unit of Radiology and IRCCS San Martino Hospital, Genova, Italy

  Tiziano Martini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.657

  50

  PDF: 17

• PO19 | Joint health status in patients with moderate hemophilia A: a cross-sectional multi-center study I.L. Calcaterra¹, F. Picasso², F. Valeri³, E. Baldacci⁴, M. Napolitano⁵, C. Guerrino¹, E. Zanon⁶, C. Santoro⁴, S. Siragusa⁷, C. Martinoli², M. Di Minno¹ | ¹Department of Clinical Medicine and Surgery, Regional Reference Centre for Coagulation Disorders, Federico II University, Naples; ²Department of Health Sciences “DISSAL”, Università di Genova; ³Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza, Turin; ⁴Haematology, Department of Translational and Precision Medicine, Sapienza University, Roma; ⁵Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo and Haematology Unit and Rare Disorders Hospital “V. Cervello”, Palermo; ⁶Haemophilia Centre, General Medicine, Padua University Hospital, Padua; ⁷Department PROMISE, University of Palermo, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.279

  601

  PDF: 25

• PO042 | ACQUIRED HEMOPHILIA A AND ANTIPHOSPHOLIPID SYNDROME: CONCURRENCY OR OVERLAPPING? E. Galimberti¹, C. Ambaglio¹, T. Zollner¹, F. Schieppati^1|2, O.C. Cretu¹, F. Zunino¹, V. Brusegan¹, M. Marchetti^1|2, A. Falanga^1|2, L. Barcella¹ | ¹Immunohematology and Transfusion Medicine, Department of Transfusion Medicine and Hematology, ERN-EuroBloodNet - European Reference Network in Rare Hematological Diseases, ASST Papa Giovanni XXIII, Bergamo, Italy; ²School of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy

  Elisa Galimberti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.858

  25

  PDF: 8

• CO-11 | MAPPING THE COMPETENCIES OF NURSES IN ITALIAN HEMOPHILIA CENTERS: CURRENT STATUS AND PERSPECTIVES FOR THE IDENTIFICATION OF NURSE-SENSITIVE OUTCOMES M.V. Puliga¹, A.C. Ferrini², C. Manzi³, D. Meneghini⁴, E. Tosi⁴, P. Berto⁵, M. Amelotti-Botta⁶, E. Quercio⁶, M.E. Mancuso⁷, R.C. Santoro⁸ | ¹SODc Malattie Emorragiche e della Coagulazione, AOU Careggi, Firenze, Italy; ²SSI Malattie Emorragiche e Tromboemboliche, Osp. Bufalini, Cesena, Italy; ³SSD Malattie Emorragiche Congenite, IRCCS Policlinico Sant'Orsola, Bologna, Italy; ⁴Centro Emofilia e UOC Medicina Trasfusionale, AOU Integrata, Verona, Italy; ⁵Centro Emofilia Hub, AO di Padova, Italy; ⁶SSD Emostasi e Coordinamento Malattie Rare, AO SS. Antonio e Biagio, Alessandria, Italy; ⁷UOC Centro Trombosi e Malattie Emorragiche, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ⁸UOD Emofilia, Emostasi e Trombosi, AOU Renato Dulbecco, Catanzaro, Italy

  Maria-Virginia Puliga

  14-10-2026

  https://doi.org/10.4081/btvb.2026.621

  89

  PDF: 16

• PO90 | Acquired hemophilia A with high-titer inhibitor in a patient with cardiovascular and metabolic comorbidities M.G. Mazzone, G. Chiarelli, R. Russo, L. Valletta Jr, G. D’Errico, C. De Luca, P. Rufolo, A. Tufano, E. Cimino, P. Conca, M.N.D. Di Minno | Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.360

  665

  PDF: 27

• BEST-06 | OPTIMIZING LABORATORY MONITORING OF EFANESOCTOCOG ALFA: IMPACT OF APTT REAGENTS AND CHROMOGENIC ASSAYS ON DIAGNOSTIC ACCURACY A. Strangio, A. Ierardi, M. Leotta, L.C. Elia, M. Falbo, C. Condina, G. Procopio, R.C. Santoro | Hemophilia Hemostasis and Thrombosis Unit, Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

  Alessandra Strangio

  14-10-2026

  https://doi.org/10.4081/btvb.2026.606

  86

  PDF: 16

• PO14 | Searching for safer rescue immunosuppressive therapy protocols in acquired hemophilia A: two case reports G. Quintavalle¹, I.M. Tassoni¹, B.M. Roccon¹, G. Lucchini², F. Magalini², M. Zardo², R. Rossi³, C. Cattabiani³, A. Tagliaferri¹, A. Coppola¹ | ¹SSD Centro HUB Emofilia e MEC; ²UOS Medicina Interna e Reumatologia; ³UO Diagnostica Ematochimica, Azienda Ospedaliero Universitaria, Parma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.275

  554

  PDF: 20

• CO-17 | EMBODIED SELF-MANAGEMENT IN HEMOPHILIA: PSYCHOSOMATIC EFFECTS OF A SUPERVISED PHYSICAL ACTIVITY PROGRAM F. Valeri¹, M. Miniotti², M.G. Bailon², C. Dainese¹, B. Bruno³, P. Leombruni², A. Borchiellini¹ | ¹Regional Centre for Haemorrhagic and Thrombotic Disease, Hematology Division, AOU Città della Salute e della Scienza, Torino, Italy; ²Departement of Neurosciences Rita Levi Montalcini, University of Turin, Italy; ³Division of Hematology, AOU Città della Salute e della Scienza, Department of Molecular Biotechnology and Health sciences, University of Turin, Italy

  Federica Valeri

  14-10-2026

  https://doi.org/10.4081/btvb.2026.627

  37

  PDF: 11

• PO040 | PHARMACODYNAMIC CHARACTERIZATION OF THROMBIN GENERATION IN SEVERE HEMOPHILIA A PATIENTS ON EMICIZUMAB PROPHYLAXIS: A REAL-WORLD LONGITUDINAL STUDY M. Bergamaschi, A. Pallotta, M. Biglietto, S. Sorella, S. Ligia, E. Baldacci, A. Chistolini, C. Santoro, R. Mormile | Department of translational and precision Medicine, Sapienza, University of Rome, Italy

  Martina Bergamaschi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.856

  24

  PDF: 8

• PO149 | MANAGEMENT OF ANTITHROMBOTIC THERAPY IN A PATIENT WITH HEMOPHILIA C AND ATRIAL FIBRILLATION E. Marrone¹, G. Ruggiero², E. Cimino³, P. Conca³, C. Miele⁴, F. Gallucci¹, A. Abate¹, C. Romano¹, D. Leosco², U. Valentino¹ | ¹Department of Medicine 3, Cardarelli Hospital, Napoli, Italy; ²School of Specialization in Geriatrics; ³Department of Internal Medicine and Blood Coagulation; ⁴Department of Laboratory Medicine and Transfusion, Federico II University, Napoli, Italy

  Emiliana Marrone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.965

  24

  PDF: 8

• CO-36 | PLATELETS MATTER: THROMBIN GENERATION IN PLATELET‐RICH-PLASMA VS. PLATELET‐POOR‐PLASMA UNDER NON-REPLACEMENT THERAPIES IN HEMOPHILIA F. Bocchi^1|2, R. Pastorino^1|2, G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^2|3, C. Dainese^2|3, A. Valpreda⁴, B. Bruno^1|3, A. Borchiellini^2|3 | ¹Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ²Regional Centre for Thrombotic and Hemorrhagic Diseases, AOU Città della salute e della Scienza di Torino, Italy; ³Division of Hematology, AOU Città della Salute e della Scienza, University of Turin, Italy; ⁴Central Lab Baldi and Riberi, AOU Città della salute e della Scienza di Torino, Italy

  Francesca Bocchi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.646

  47

  PDF: 14

• CO34 | Evaluation of emicizumab concentration and thrombin generation in a cohort of severe hemophilia A patients with and without inhibitor A. Taglietti¹, S. Ligia¹, F. Paoletti¹, R. Mormile¹, E. Baldacci², A. Chistolini¹, C. Santoro^1,2 | ¹Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma; ²Hematology, Azienda Ospedaliera Universitaria Policlinico Umberto I, Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.241

  676

  PDF: 12

• CO-85 | ACQUIRED HEMOPHILIA A IN LIVER CIRRHOSIS: BALANCING HEMOSTASIS BETWEEN HIGH HEMORRHAGIC AND THROMBOTIC RISKS N. Portesi, G. Martini | ASST Spedali Civili di Brescia, Italy

  Nicola Portesi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.695

  43

  PDF: 19

• CO-09 | THE POSSIBLE ROLE OF THE PSYCHOLOGIST IN THE MANAGEMENT OF PATIENTS WITH CONGENITAL BLEEDING DISORDERS: THE EXPERIENCE OF A SINGLE HEMOPHILIA CENTER D. Meneghini¹, E. Tosi¹, B. Pernice², L. Del Piccolo², M. Bodini¹, A.C. Giuffrida¹ | ¹Transfusion Medicine Dep., Integrated University Hospital, Verona, Italy; ²Dep. of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy

  Marco Bodini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.619

  89

  PDF: 13

• BEST-04 | MAJOR ORTHOPEDIC SURGERY WITH EMICIZUMAB: A SERIES OF 22 PATIENTS (40 PROCEDURES) WITH A MID-TERM FOLLOW-UP G. Daniele¹, C. Carulli¹, S. Linari², L. Pieri², G. Castaman² | ¹Clinica Ortopedica, Azienda Ospedaliero-Universitaria Careggi, Università degli Studi di Firenze, Italy; ²Centro Malattie Emorragiche e della Coagulazione, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

  Giovanna Daniele

  14-10-2026

  https://doi.org/10.4081/btvb.2026.604

  86

  PDF: 13
• 

  Inherited platelet function disorders: a comprehensive narrative review focusing on diagnostic and management aspects

  Antonietta Ferretti, Nicola Portesi, Chiara Gorio, Marzia Leotta, Alessandra Strangio, Antonella Ierardi, Bianca Maria Roccon, Giulia Albrici, Giulia Carracchia, Marta Mattana, Chiara Biasoli, Cristina Santoro, Tiziano Martini, Rita Carlotta Santoro

  21-10-2026

  https://doi.org/10.4081/btvb.2026.581

  56

  PDF: 38

  SUPPLEMENTARY MATERIAL: 12
• 

  Gene transfer in hemophilia B: a big step forward

  Giancarlo Castaman

  17-05-2023

  https://doi.org/10.4081/btvb.2023.70

  1436

  PDF: 659

• PO136 | PHENOTYPE CHARACTERIZATION OF PATIENTS HOSPITALIZED FOR ACUTE SARS-COV2 INFECTION WITH AND WITHOUT ACUTE CEREBRAL ISCHEMIA P. Agosti^1|2, R. Gualtierotti^1|2, C. Suffritti¹, L. Valenti^2|3, M. Morena², M. Tettamanti⁴, A. Nobili⁴, A. Bandera^2|5, F. Peyvandi^1|2 | ¹Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; ²Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milano, Italy; ³Department of Transfusion Medicine and Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; ⁴Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy; ⁵Department of Infectious Diseases, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milano, Italy

  Pasquale Agosti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.952

  26

  PDF: 11

• CO49 | The burden of cerebral small vessel disease in ITTP patients from acute phase to remission A. Truma^1,2, F. M. Lo Russo¹, G. Conte^1,2, I. Mancini¹, M. Abbattista¹, J. A. Giannotta¹, A. Artoni¹, B. Ferrari¹, P. Agosti^1,2, F. M. Triulzi^1,2, F. Peyvandi^1,2 | ¹Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan; ²Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.259

  628

  PDF: 15
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  https://doi.org/10.4081/btvb.2022.10

  1890

  PDF: 564

  APPENDIX: 144

• CO-14 | BEYOND BLEEDING: NARRATIVE MEDICINE AS A METHODOLOGICAL TOOL FOR INVESTIGATION AND CARE IN CONGENITAL BLEEDING DISORDERS V. Grippa¹, S. Riva², A. Gringeri³ | ¹Centro Malattie Emorragiche Salerno, Italy; ²St. Mary's University, London, UK; ³Fondazione Charta, Milano, Centro di Solidarietà Solidale, Lucca, Italy

  Silvia Riva

  14-10-2026

  https://doi.org/10.4081/btvb.2026.624

  72

  PDF: 19

• CS05 | Joint ultrasound follow-up in pediatric patients with haemophilia: a 12-year prospective single-center experience B. Borsellino^1,2, B. Pollio¹, C. Martinoli³, T. Martini¹, R. Albiani¹, I. Ricca¹ | ¹Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Turin; ²Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Roma Tor Vergata, Roma; ³Department of Health Science DISSAL, University of Genoa, Unit of Radiology and IRCCS San Martino Hospital, Genoa, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.202

  683

  PDF: 28

• CO-74 | WHAT WOMEN ARE NOT ASKED A MODEL OF CARE FOR WOMEN AND GIRLS WITH BLEEDING DISORDERS S. Pancetti, A.C. Ferrini, E. Magnani, P. Pedrazzi, C. Biasoli | Osp. M.Bufalini, Cesena, Italy

  Saverio Pancetti

  14-10-2026

  https://doi.org/10.4081/btvb.2026.684

  45

  PDF: 13

• PO39 | Bleeding events in Von Willebrand disease type 1 yearly treatable with desmopressin A. Gringeri^1,2, P.M. Mannucci³, M. Gringeri⁴, G. Castaman⁵, F. Peyvandi^3,6 | ¹Fondazione Charta, Milan; ²Centro di Sanità Solidale, Lucca; ³Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan; ⁴Department of Medical Biotechnologies and Translational Medicine, Postgraduate School of Clinical Pharmacology and Toxicology, University of Milan; ⁵Centre for Bleeding Disorders and Coagulation, Careggi University Hospital, Firenze; ⁶Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.302

  645

  PDF: 23

• CO-41 | COMPARISON OF COAGULATION AND CHROMOGENIC METHODS IN PHARMACOKINETICS WITH EXTENDED HALF-LIFE FACTOR VIII R. Pastorino^1|2, F. Bocchi^1|2, G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^2|3, C. Dainese^2|3, A. Valpreda⁴, B. Bruno^1|3, A. Borchiellini^2|3 | ¹Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ²Regional Centre for Thrombotic and Hemorrhagic Diseases, AOU Città della salute e della Scienza di Torino, Italy; ³Division of Hematology, AOU Città della Salute e della Scienza, University of Turin, Italy; ⁴Central Lab Baldi and Riberi, AOU Città della salute e della Scienza di Torino, Italy

  Rebecca Pastorino

  14-10-2026

  https://doi.org/10.4081/btvb.2026.651

  39

  PDF: 14
• 

  Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

  Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele

  08-05-2024

  https://doi.org/10.4081/btvb.2024.106

  2859

  PDF: 739

• BEST-01 | IDENTIFICATION OF NOVEL HYPERACTIVE rFVIIa BYPASSING MOLECULES INFERRED BY ANCESTRAL SEQUENCE RECONSTRUCTION APPROACH M.F. Testa, I. Passerini, P. Santos, A. Benazzo, S. Ghirotto, F. Bernardi, A. Branchini, M. Pinotti, D. Balestra | Dep. of LSB, University of Ferrara, Italy

  Maria Francesca Testa

  14-10-2026

  https://doi.org/10.4081/btvb.2026.601

  112

  PDF: 24

• PO24 | Emicizumab prophylaxis and bleeding outcomes: a single center clinical experience A. Taglietti¹, S. Ligia¹, F. Paoletti¹, R. Mormile¹, E. Baldacci², A. Chistolini¹, C. Santoro^1,2 | ¹Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma; ²Hematology, Azienda Ospedaliera Universitaria Policlinico Umberto I, Roma, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.285

  625

  PDF: 22
• 

  Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

  Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

  21-03-2023

  https://doi.org/10.4081/btvb.2023.59

  1307

  PDF: 393

• CO-19 | A CASE OF LOSS OF EFFICACY OF EMICIZUMAB AFTER 6 YEARS OF REGULAR USE M.R. Fasulo¹, I. Quaglia¹, A. Colombo¹, C. Lodigiani¹, M.E. Mancuso^1|2 | ¹Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ²Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy

  Maria Rosaria Fasulo

  14-10-2026

  https://doi.org/10.4081/btvb.2026.629

  45

  PDF: 16

• CO31 | Immune system profiling in FVIII-treated and emicizumab-treated pediatric HA patients A. Cottonaro¹, S. Akula¹, B. Pollio², I. Ricca², T. Martini², J. Agnelli Giacchello³, P. Sciancalepore³, R. Santi³, A. Follenzi^1,3, S. Merlin¹ | ¹Università del Piemonte Orientale, Health Sciences, Novara; ²A.O. Città della Salute e della Scienza, SIMT Immunohematology and Transfusion Medicine Service, Diagnostic Department, Torino; ³Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.238

  644

  PDF: 15

• PO127 | ANAPHYLACTIC REACTION TO RECOMBINANT ACTIVATED FVII IN A MILD HEMOPHILIA A PATIENT WITH INHIBITOR: A CASE REPORT I. Nichele, G. Carli, G. Marchesini, A. Tosetto | Haematology Department, S. Bortolo Hospital, Vicenza, Italy

  Ilaria Nichele

  26-10-2026

  https://doi.org/10.4081/btvb.2026.943

  19

  PDF: 11

• CO080 | INVESTIGATING MECHANISMS OF ACQUIRED VON WILLEBRAND SYNDROME ACROSS HEMATOLOGICAL DISEASES: THE CONTRIBUTION OF INTRAPLATELET VWF A. Ciavarella¹, L. Baronciani¹, O. Seidizadeh¹, P. Colpani¹, F. Boggio¹, D. Cattaneo^2|3, S. Ceglie¹, M.T. Pagliari¹, A. Iurlo², S.M. Siboni¹, F. Peyvandi^1|4 | ¹Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; ²Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; ³Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy; ⁴Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy

  Alessandro Ciavarella

  26-10-2026

  https://doi.org/10.4081/btvb.2026.782

  30

  PDF: 10
• 

  Availability of direct oral anticoagulants testing among Italian anticoagulation clinics: a rapid evolution of clinical practice On behalf of the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies

  Daniela Poli, Antonio Ciampa, Valeria De Micheli, Angela Maria Iannone, Giuseppe Malcangi, Giuseppe Rescigno, Cinzia Scarone, Sophie Testa, Marco Marietta

  26-06-2026

  https://doi.org/10.4081/btvb.2026.485

  874

  PDF: 101

• 29th National Conference of the Italian Society for the Study of Hemostasis and Thrombosis, 2025

  Guest Editor: Valerio De Stefano

  22-10-2025

  https://doi.org/10.4081/btvb.2025.408

  883
• 

  Remembering the XXVI SISET Congress and the 50th anniversary of its foundation, 2020

  Armando Tripodi

  17-01-2025

  https://doi.org/10.4081/btvb.2025.171

  1687

  PDF: 317

• PO021 | PLATELETS MATTER: THROMBIN GENERATION IN PLATELET‐RICH PLASMA VERSUS PLATELET-POOR-PLASMA UNDER NON-REPLACEMENT THERAPIES IN HAEMOPHILIA F. Bocchi^1|2, R. Pastorino^1|2, G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^2|3, C. Dainese^2|3, A. Valpreda⁴, B. Bruno^1|3, A. Borchiellini^2|3 | ¹Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy; ²Regional Centre for Thrombotic and Hemorrhagic Diseases; ³Division of Hematology; ⁴Central Lab Baldi and Riberi, AOU Città della salute e della Scienza di Torino, Torino, Italy

  Francesca Bocchi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.837

  21

  PDF: 10

• CO-72 | HEREDITARY FACTOR X DEFICIENCY UNMASKED BY NECROTIZING HEMORRHAGIC PANCREATITIS: A CASE REPORT M. Leotta, A. Strangio, A. Ierardi, R.C. Santoro | Hemophilia Treatment Center AOU Dulbecco, Catanzaro, Italy

  Marzia Leotta

  14-10-2026

  https://doi.org/10.4081/btvb.2026.682

  33

  PDF: 16
• 

  Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition

  Boris Shenkman, Ivan Budnik, Yulia Einav

  16-02-2023

  https://doi.org/10.4081/btvb.2023.51

  1882

  pdf: 492
• 

  Direct oral anticoagulants: does one dose fit all? Why, when and how testing

  Armando Tripodi

  15-01-2026

  https://doi.org/10.4081/btvb.2026.418

  1435

  PDF: 296
• 

  Influence of emicizumab on protein C-mediated clotting regulation

  Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

  25-10-2023

  https://doi.org/10.4081/btvb.2023.89

  2654

  PDF: 447

  Supplementary Material: 141

• CO079 | FVIII DEFICIENCY COMPROMISES IN VITRO OSTEOBLASTS MINERALIZATION AND THEIR SECRETOME PROFILE B. Terkawi, P.E. Di Simone, V. Kalandadze, A. Follenzi, C. Borsotti | Histology lab, upo, novara, Italy

  Baker Terkawi

  26-10-2026

  https://doi.org/10.4081/btvb.2026.781

  22

  PDF: 10

• PO074 | DEVELOPMENT OF INNOVATIVE LONG-ACTING FACTOR IX AND FACTOR X VARIANTS VIA CONDITIONAL ALBUMIN FUSION A. Martucci¹, R. Tarantino¹, K.H. Aaen², M. Pinotti¹, J.T. Andersen², A. Branchini¹ | ¹Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy; ²Institute of Clinical Medicine, Department of Pharmacology, University of Oslo, Oslo, Norway

  Alessandro Martucci

  26-10-2026

  https://doi.org/10.4081/btvb.2026.890

  27

  PDF: 8

• CO-87 | SPONTANEOUS HEMATOMA IN A PATIENT WITH POLYCYTHEMIA VERA: A CASE OF ACQUIRED VON WILLEBRAND DISEASE? A. Strangio, A. Ierardi, M. Leotta, R.C. Santoro | Hemophilia center, AOU Renato Dulbecco, Catanzaro, Italy

  Alessandra Strangio

  14-10-2026

  https://doi.org/10.4081/btvb.2026.697

  50

  PDF: 17
• 

  The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

  Armando Tripodi

  23-01-2025

  https://doi.org/10.4081/btvb.2025.169

  1473

  PDF: 420

• PO015 | OSA VS. CHA FOR RPFVIII MEASURE: STILL AN ISSUE? G. Gazzelli, Y. Azzanelli, C. Vernarecci, F. Marotta, F. Giacopelli, B. Tappino, L. Banov, A.C. Molinari | IRCCS Istituto Giannina Gaslini Genova, Italy

  Angelo Claudio Molinari

  26-10-2026

  https://doi.org/10.4081/btvb.2026.831

  24

  PDF: 7

• CO-71 | ACQUIRED FACTOR XIII DEFICIENCY IN A PATIENT POST-CAR-T THERAPY FOR NON-HODGKIN LYMPHOMA: A CASE REPORT A. Strangio, M. Leotta, A. Ierardi, R.C. Santoro | Hemophilia, Hemostasis and Thrombosis Unit, Azienda Ospedaliero Universitaria Renato Dulbecco, Catanzaro, Italy

  Alessandra Strangio

  14-10-2026

  https://doi.org/10.4081/btvb.2026.681

  41

  PDF: 19
• 

  Launch of a National Registry for Congenital Hematological Disorders in Palestine: the Haemo-PAL Initiative

  Fabio Candura, Emanuela Marchesini, Gian Luca Forni, Alessandro Gringeri, Ilaria Gentilini, Mirko Tricoli, Osama Najjar, Luciana Teofili

  15-01-2026

  https://doi.org/10.4081/btvb.2026.417

  1146

  PDF: 236
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  https://doi.org/10.4081/btvb.2023.84

  2164

  PDF: 648

  Supplementary File: 289

• CO036 | NEUROCOGNITIVE ASSESSMENT OF IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA PATIENTS USING A COMPREHENSIVE TEST BATTERY IN A CROSS-SECTIONAL MRI-INTEGRATED STUDY A. Truma¹, T. Difonzo², F. Lo Russo³, G. Conte^3|4, I. Mancini¹, E. Cesari¹, M. Gagliardi¹, J.A. Giannotta¹, A. Artoni¹, E. Piccin³, P. Agosti⁴, F. Triulzi^3|4, F. Peyvandi^1|4 | ¹Fondazione IRCCS Ca’ Granda ospedale maggiore policlinico, Angelo Bianchi Bonomi hemophilia and thrombosis center, Milano, Italy; ²Fondazione IRCCS Ca’ Granda ospedale maggiore policlinico, neurology unit, Milano, Italy; ³Fondazione IRCCS Ca’ Granda ospedale maggiore policlinico, neuroradiology unit, Milano, Italy; ⁴Università degli studi di Milano, Milano, Italy

  Addolorata Truma

  26-10-2026

  https://doi.org/10.4081/btvb.2026.738

  25

  PDF: 9

• CO-44 | EVALUATION OF THE DEVIATION BETWEEN PRESCRIBED AND RECOMMENDED EMICIZUMAB DOSING IN PATIENTS WITH CONGENITAL HEMOPHILIA A A.C. Giuffrida¹, S. Abeysinghe Gunawardhana¹, S. Amato², F. Casoli², C. Recchi², M. Saggioro², E. Bonetti³, M. Bodini¹, G. Poli² | ¹Centro Emofilia, UOC Medicina Trasfusionale, AOUI Verona, Italy; ²UOC Laboratorio Analisi, AOUI Verona, Italy; ³UOC Oncoematologia Pediatrica, AOUI Verona, Italy

  Marco Bodini

  14-10-2026

  https://doi.org/10.4081/btvb.2026.654

  44

  PDF: 14

• CO033 | THE BURDEN OF CEREBRAL SMALL VESSEL DISEASE AND GLOBAL CORTICAL ATROPHY IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA DURING REMISSION A. Truma¹, F. Lo Russo², G. Conte^2|3, I. Mancini¹, E. Cesari¹, M. Gagliardi¹, J.A. Giannotta¹, A. Artoni¹, E. Piccin², P. Agosti³, F. Triulzi^2|3, F. Peyvandi^1|3 | ¹Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milano, Italy; ²Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Neuroradiology Unit, Milano, Italy; ³Università degli Studi di Milano, Milano, Italy

  Addolorata Truma

  26-10-2026

  https://doi.org/10.4081/btvb.2026.735

  26

  PDF: 8

• CO-43 | VALIDATION OF THROMBIN GENERATION MEASUREMENT IN PLATELET-RICH PLASMA: EVOLUTION IN THE ST GENESIA^® SYSTEM F. Bocchi^1|2, R. Pastorino^1|2, G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^2|3, C. Dainese^2|3, A. Valpreda⁴, B. Bruno^1|3, A. Borchiellini^2|3 | ¹Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; ²Regional Centre for Thrombotic and Hemorrhagic Diseases, AOU Città della salute e della Scienza di Torino, Italy; ³Division of Hematology, AOU Città della Salute e della Scienza, University of Turin, Italy; ⁴Central Lab Baldi and Riberi, AOU Città della salute e della Scienza di Torino, Italy

  Francesca Bocchi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.653

  34

  PDF: 14

• PO146 | COMPARISON OF COAGULATION AND CHROMOGENIC METHODS IN PHARMACOKINETICS WITH EXTENDED HALF-LIFE FACTOR VIII R. Pastorino^1|2, F. Bocchi^1|2, G. Murante^1|2|3, S. Bergonzi^1|2|3, M. Capetta^1|2|3, F. Valeri^2|3, C. Dainese^2|3, A. Valpreda⁴, B. Bruno^1|3, A. Borchiellini^2|3 | ¹Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy; ²Regional Centre for Thrombotic and Hemorrhagic Diseases; ³Division of Hematology; ⁴Central Lab Baldi and Riberi, AOU Città della salute e della Scienza di Torino, Torino, Italy

  Rebecca Pastorino

  26-10-2026

  https://doi.org/10.4081/btvb.2026.962

  23

  PDF: 9

• CO109 | THE ROLE OF SELECTED LDLR AND LRP1 VARIANTS IN MODULATING LDL AND FVIII LEVELS IN METABOLIC SYNDROME P. Agosti^1|2, A. Cairo², S. Spena², S. Pelusi³, F. Malvestiti¹, D. Prati³, M. Clerici², E. Scalambrino², A. Tripodi^1|2, V. La Mura^1|2, L. Valenti^1|3, F. Peyvandi^1|2 | ¹Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milano, Italy; ²Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, and Fondazione Luigi Villa, Milano, Italy; ³Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

  Pasquale Agosti

  26-10-2026

  https://doi.org/10.4081/btvb.2026.811

  19

  PDF: 10

• CO-68 | ACQUIRED FACTOR XIII DEFICIENCY ASSOCIATED WITH CROHN’S DISEASE: A CHALLENGING DIAGNOSTIC AND THERAPEUTIC CASE A. Colombo¹, A. Dal Buono^2|3, I. Quaglia¹, C. Novembrino⁴, M.R. Fasulo¹, C. Lodigiani¹, M.E. Mancuso^1|2 | ¹Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ²Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy; ³IBD Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy; ⁴Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milano, Italy

  Arianna Colombo

  14-10-2026

  https://doi.org/10.4081/btvb.2026.678

  45

  PDF: 12

• CO51 | Novel biomarkers of neurological damage in acute immune-mediated thrombotic thrombocytopenic purpura A. Truma^1,2, I. Mancini¹, F. Verde^2,3, J. A. Giannotta¹, A. Artoni¹, B. Ferrari¹, P. Agosti^1,2, M. Gagliardi¹, A. Ratti^3,4, N. Ticozzi^2,3, F. Peyvandi^1,2 | ¹Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan; ²Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan; ³Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan; ⁴Università degli Studi di Milano, Department of Medical Biotechnology and Translational Medicine, Milan, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.261

  590

  PDF: 14
• 

  An ecological alliance against air pollution and cardiovascular disease

  Pier Mannuccio Mannucci

  22-03-2022

  https://doi.org/10.4081/btvb.2022.21

  2161

  PDF: 499

• CS06 | Patient specific iPSCs-derived sinusoidal endothelial cells for phenotypic correction of haemophilia A A. Benetti¹, C.M. Radu¹, C. Samà¹, M. Trevisan², C. Simion¹, E. Campello¹, P. Simioni¹ | ¹Department of Medicine - DIMED, Padua University Hospital; ²Department of Molecular Medicine, University of Padua, Italy

  22-10-2025

  https://doi.org/10.4081/btvb.2025.203

  730

  PDF: 20

• CO-84 | PARAPROTEIN-DRIVEN ACQUIRED VON WILLEBRAND SYNDROME IN A PATIENT WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND UROTHELIAL CARCINOMA A. Ierardi, A. Strangio, M. Leotta, R.C. Santoro | Hemostasis Unit, AOU Dulbecco, Catanzaro, Italy

  Antonella Ierardi

  14-10-2026

  https://doi.org/10.4081/btvb.2026.694

  38

  PDF: 15